Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
10/08/2022 12:58
Aug 10 (Reuters) - Bionik Laboratories Corp BNKL.PK :
* BIONIK LABORATORIES REPORTS FIRST QUARTER FINANCIAL RESULTS
* Q1 NON-GAAP LOSS PER SHARE $0.19
* Q1 GAAP LOSS PER SHARE $0.20
* Q1 REVENUE $200,000 VERSUS $700,000
Source text for Eikon: ID:nBw1V434Ya
Further company coverage: BNKL.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionik Laboratories
See all newsBrief: Bionik Laboratories Reports A Significant Increase In Patient Volume At Its Acquired Rehabilitation Center In Florida
Brief: Bionik Laboratories Enters Into Distribution Agreement With Pro-Med Technology For The Sale Of Inmotion® Robotic Devices In Hong Kong
Brief: Bionik Laboratories acquires Florida Rehabilitation Center first in strategic national rollout
Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
Brief: Bionik Laboratories Says Chief Commercial Officer, Terminated Other Than For Cause From Employment, Officer Positions With Co, Units